天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2015年
8期
876-878,879
,共4页
石亚楠%黄河玲%郭瑞峰%刘艺
石亞楠%黃河玲%郭瑞峰%劉藝
석아남%황하령%곽서봉%류예
半乳糖凝集素3%β连环素%子宫内膜异位症%免疫组织化学
半乳糖凝集素3%β連環素%子宮內膜異位癥%免疫組織化學
반유당응집소3%β련배소%자궁내막이위증%면역조직화학
Galectin 3%beta catenin%endometriosis%immunohistochemistry
目的:探讨半乳糖凝集素-3(Galectin-3)和β连环素(β-catenin)在子宫内膜异位症(EMs)患者的异位内膜和在位内膜中的表达及其在EMs发病中的作用及关系。方法应用免疫组织化学法检测34例EMs患者(EMs组)的异位内膜和在位内膜及30例非子宫内膜异位症(正常对照组)的在位子宫内膜中的半乳糖凝集素-3和β连环素的表达情况,并分析二者的相关性。结果半乳糖凝集素-3在EMs组异位内膜、在位内膜及正常对照组在位内膜的阳性表达率分别为88.2%、85.3%、50.0%;β连环素在上述3组的异常表达率分别为55.9%、52.9%、26.7%。EMs异位内膜组、在位内膜组的半乳糖凝集素-3的阳性表达率和β连环素的异常表达率均高于正常对照组(P<0.05)。EMs组异位内膜、在位内膜中的半乳糖凝集素-3的阳性表达和β连环素的异常表达呈正相关(rs分别为0.512、0.428,P<0.01)。结论半乳糖凝集素-3和β连环素可能在EMs的发病中共同起着重要作用。
目的:探討半乳糖凝集素-3(Galectin-3)和β連環素(β-catenin)在子宮內膜異位癥(EMs)患者的異位內膜和在位內膜中的錶達及其在EMs髮病中的作用及關繫。方法應用免疫組織化學法檢測34例EMs患者(EMs組)的異位內膜和在位內膜及30例非子宮內膜異位癥(正常對照組)的在位子宮內膜中的半乳糖凝集素-3和β連環素的錶達情況,併分析二者的相關性。結果半乳糖凝集素-3在EMs組異位內膜、在位內膜及正常對照組在位內膜的暘性錶達率分彆為88.2%、85.3%、50.0%;β連環素在上述3組的異常錶達率分彆為55.9%、52.9%、26.7%。EMs異位內膜組、在位內膜組的半乳糖凝集素-3的暘性錶達率和β連環素的異常錶達率均高于正常對照組(P<0.05)。EMs組異位內膜、在位內膜中的半乳糖凝集素-3的暘性錶達和β連環素的異常錶達呈正相關(rs分彆為0.512、0.428,P<0.01)。結論半乳糖凝集素-3和β連環素可能在EMs的髮病中共同起著重要作用。
목적:탐토반유당응집소-3(Galectin-3)화β련배소(β-catenin)재자궁내막이위증(EMs)환자적이위내막화재위내막중적표체급기재EMs발병중적작용급관계。방법응용면역조직화학법검측34례EMs환자(EMs조)적이위내막화재위내막급30례비자궁내막이위증(정상대조조)적재위자궁내막중적반유당응집소-3화β련배소적표체정황,병분석이자적상관성。결과반유당응집소-3재EMs조이위내막、재위내막급정상대조조재위내막적양성표체솔분별위88.2%、85.3%、50.0%;β련배소재상술3조적이상표체솔분별위55.9%、52.9%、26.7%。EMs이위내막조、재위내막조적반유당응집소-3적양성표체솔화β련배소적이상표체솔균고우정상대조조(P<0.05)。EMs조이위내막、재위내막중적반유당응집소-3적양성표체화β련배소적이상표체정정상관(rs분별위0.512、0.428,P<0.01)。결론반유당응집소-3화β련배소가능재EMs적발병중공동기착중요작용。
Objective To investigate the expressions and mutual relationship of Galectin-3 andβ-catenin in endome?triosis (EM). Methods Immunohistochemistry was used to detect expression levels of Galectin-3 andβ-catenin and their mutual relationship in expression was also examined. Samples were collected from ectopic endometrium of patients with en?dometriosis (ectopic endometrium group, n=34), eutopic endometrium of patients with endometriosis (eutopic endometrium group, n=34) and normal endometrium from people without endometriosis (control group, n=30). Results The expressions of Galectin-3 were seen in 88.2%, 85.3%, 50.0%of cases in ectopic endometrium group, eutopic endometrium group and control group respectively. On the other hand, the expression ofβ-catenin were seen in 55.9%, 52.9%, 26.7%of cases in ecto?pic endometrium group, eutopic endometrium group and control group respectively. In EMs patients, the expression of Galec?tin-3 andβ-catenin were significantly higher in ectopic endometrium and eutopic endometrium than those in normal endome?trium group(P<0.05). Expression of Galectin-3 was positive correlated with expression ofβ-catenin(rs=0.512, 0.428, P<0.01). Conclusion Galectin-3 andβ-catenin may play important roles synergistically in the pathogenesis of endometriosis.